Earnings Release • Aug 27, 2013
Earnings Release
Open in ViewerOpens in native device viewer
News Details
Corporate | 27 August 2013 12:53
MPH Mittelständische Pharma Holding AG: 1st half-year 2013: sales of EUR 112.38 million; substantial build-up of hidden reserves
MPH Mittelständische Pharma Holding AG / Key word(s): Half Year Results/Quarter Results
27.08.2013 / 12:53
MPH Mittelständische Pharma Holding AG:
1st half-year 2013: sales of EUR 112.38 million; substantial build-up of hidden reserves
The MPH Group generated sales of EUR 112.38 million (previous year: EUR 99.29 million) in the first half of 2013 and thus an increase of 13.2 % compared to the same period of the previous year. The earnings before interest and tax (EBIT) amounted to EUR 5.68 million. The net profit totaled EUR 4.23 million.
Due to the extension of the basis of consolidation the profit recognized directly in equity was EUR 7.47 million.
Equity expanded by EUR 11.7 million in the first half of 2013.
The market value of the Pharma segment listed in the Entry Standard of the Frankfurt stock exchange, HAEMATO AG, rose by EUR 35.5 million in the first half-year. Thereby the MPH, as the majority shareholder, could build up substantial hidden reserves.
About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on growth segments Pharma and Healthcare. On the basis of patent-free and patent-protected active substances, production and consultancy services for therapies of chronic diseases, the Group makes a precious contribution to keeping health affordable.
MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 41,167,155
Listed shares: Preference shares
Number of preference shares in circulation: 19,025,000
ISIN: DE000A0NF697
WKN: A0NF69
Stock symbol: 93MV
Contact:
Linda Reichelt
MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
D-10623 Berlin
Phone:+49 (0) 30 897 30 86 60 Fax:+49 (0) 30 897 30 86 69
E-Mail: [email protected] Web: www.mph-ag.de
End of Corporate News
27.08.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
| Language: | English |
| Company: | MPH Mittelständische Pharma Holding AG |
| Fasanenstraße 77 | |
| 10623 Berlin | |
| Germany | |
| Phone: | 030 / 897 308 660 |
| Fax: | 030 / 897 308 670 |
| E-mail: | [email protected] |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A0NF697 |
| WKN: | A0NF69 |
| Listed: | Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard) |
| End of News | DGAP News-Service |
| - - - |
| 227692 27.08.2013 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.